Test Price
2,800 AED✅ Home Collection Available
MED13L Gene NGS Test (Transposition of the Great Arteries, Dextro‑looped Type 1) – 2,800 AED
Executive Summary & Core Metrics
- ✓ 99.9% Diagnostic Sensitivity – Full‑gene NGS covering SNVs, indels, and CNVs with ISO‑certified processing.
- ✓ VIP Mobile Phlebotomy & Cold‑Chain Home Collection – Available daily 8 AM–11 PM across the UAE.
- ✓ Post‑Test Genetic Counselling – Telephonic interpretation by a consultant medical geneticist.
- ✓ Insurance Pre‑Authorisation – Direct billing verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
This next‑generation sequencing (NGS) test screens the entire coding region of the MED13L gene for pathogenic variants linked to transposition of the great arteries (dextro‑looped type 1) and associated dysmorphology. The analysis is performed on a clinical‑grade Illumina platform with >99.9% call rate for single‑nucleotide variants and small indels.
| Feature | MED13L NGS (Our Test) | Single‑Exon Sanger |
|---|---|---|
| Precision | Full‑gene coverage, detects SNVs, indels, CNVs | Limited to pre‑selected exons only |
| Method | Next‑Generation Sequencing (NGS) | Sanger sequencing |
| Turnaround Time | 3 – 4 weeks | 4 – 6 weeks |
| Clinical Sensitivity | 99.9% | ~75% (mutation‑dependent) |
Physician Insight & Safety Protocols
“I understand the deep anxiety that accompanies genetic testing for a child. A positive MED13L variant confirms a complex congenital condition, but it is not a diagnosis in isolation – clinical correlation with a paediatric cardiologist and geneticist is essential. I will personally ensure you receive clear, empathic guidance through every step of the results interpretation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠ Medication Advisory
Do not discontinue any prescribed medication without consulting your doctor. This genetic test does not replace clinical management decisions.
Exclusion Criteria & Emergency Red Flags
- This test is not a substitute for emergency neonatal echocardiography or urgent surgical evaluation.
- Do not use this test for asymptomatic minors without prior genetic counselling and parental consent.
- Seek immediate medical attention if the child shows cyanosis, respiratory distress, or collapse—these require emergency care, not laboratory testing.
Patient FAQ & Clinical Guidance
1. What is the MED13L gene and why is this test ordered?
This test sequences the MED13L gene to detect mutations that cause transposition of the great arteries, a critical congenital heart defect. It helps confirm a diagnosis, guide surgical planning, and inform family recurrence risk.
2. How is the sample collected and how long until I receive results?
A simple blood draw or a dried blood spot on an FTA card is all that’s needed; results are ready in 3–4 weeks. Our VIP mobile phlebotomist can collect the sample at your home between 8 AM and 11 PM, with temperature‑controlled cold‑chain transport.
3. Is the MED13L NGS covered by health insurance in the UAE?
We offer direct billing verification with major UAE insurers. Contact us via WhatsApp for pre‑authorisation before sample collection to confirm coverage and avoid out‑of‑pocket costs.
UAE Regulatory & Data Privacy Adherence
🔒 Your Data, Our Compliance
All genetic data is processed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. Results are encrypted and accessible only to authorised medical professionals.
Clinical & Logistical Metadata
| Test Name | MED13L Gene NGS (Transposition of the Great Arteries, Dextro‑looped Type 1) |
| Price (AED) | 2,800 |
| Turnaround Time | 3 – 4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3 mL EDTA) or dried blood spot on FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina platform |
| ICD-10-CM Code | Q20.3 (Transposition of great vessels) |
| LOINC Code | 89848-3 (MED13L gene mutation analysis) |
| DHA Facility License & Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians